Recently, Watt et al. identified CD36 to be an essential regulator of lipid metabolism in patient-derived PCa xenograft mouse models, thereby promoting CD36-dependent PCa cancer progression [27]. The gene discussed is CD36; the disease is posterior cortical atrophy.